Imitation Ozempic products pose serious health risks to consumers Brand-name Ozempic costs $800-$1,000 per month, limiting ...

智通财经APP获悉，在美国食品药品监督管理局 (FDA)决定将礼来公司 (LLY.US)的替西帕肽 (Tirzepatide)从药品短缺清单中移除后，一起针对此次除名举措的诉讼引发了Hims & Hers Health (HIMS.US)周一交易上涨 ...

The proposal, unveiled at the government's International Investment Summit today is headlined by the creation of a UK biotech ...

Analyst David Larsen from BTIG maintained a Buy rating on LifeMD (LFMD – Research Report) and keeping the price target at $12.00. David ...

Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...

The FDA said in a court filing late Friday that it would allow pharmacists to continue making compounded versions of ...

Analyst Glen Santangelo of Jefferies maintained a Hold rating on Hims & Hers Health (HIMS – Research Report), with a price target of ...

Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Trump hedges on abortion banFormer ...

The Food and Drug Administration (FDA) said it will reconsider its decision to remove Eli Lilly’s blockbuster weight loss and ...

In response to rising demand for weight loss medications, WeightWatchers has launched a low-cost alternative to ...

Hims & Hers Health saw its shares surge by 7% today after the FDA announced that it would reconsider its decision to limit ...

The agency agreed in court to allow compounding companies to continue producing copycat versions of Lilly’s fast-selling ...